By the clinical team at Next Step Psychiatry • Lilburn, GA
One of the most common concerns patients express about Spravato is cost. Treatment-resistant depression is devastating enough without financial barriers blocking access to effective treatment. At Next Step Psychiatry in Lilburn, we understand the insurance landscape and want to help you navigate it. With proper documentation and understanding of insurance requirements, many patients can get Spravato approved and covered.
Current Insurance Coverage Status for Spravato
Insurance coverage for Spravato has evolved significantly since FDA approval in 2019. In 2026, most major insurance plans—including Medicare, Medicaid, and commercial insurers—cover Spravato for treatment-resistant depression when appropriate criteria are met. The coverage isn’t automatic, but the pathway has become increasingly clear.
Georgia Medicaid and Medicare beneficiaries in the Atlanta metro area have good access to Spravato coverage. Most commercial plans like Anthem, UnitedHealth, Aetna, and Cigna cover Spravato. The key is meeting medical necessity requirements and completing prior authorization.
What Insurance Companies Require
To get Spravato approved, insurance companies require documentation proving treatment-resistant depression. This means:
- Diagnosis of major depressive disorder documented in medical records
- At least two adequate antidepressant trials at therapeutic doses for at least 4–6 weeks each (or longer for some medications)
- Documentation of why previous medications didn’t work (ineffective, intolerable side effects, etc.)
- Current significant depressive symptoms causing functional impairment
- Letter from prescribing psychiatrist explaining medical necessity
Insurance companies want to ensure they’re approving Spravato for appropriate patients, not as a first-line treatment. They need to see that standard treatment has been genuinely attempted before this expensive medication is pursued.
The Prior Authorization Process
Prior authorization is the insurance company’s formal approval process before treatment. At Next Step Psychiatry, we handle most of this administrative burden for you. Here’s how it typically works:
Step 1: You’re evaluated by our psychiatrist and determined to be a candidate for Spravato. Step 2: We gather your medication history and documentation of prior treatment trials from your records. Step 3: We submit a prior authorization request to your insurance company with supporting clinical documentation. Step 4: Insurance company reviews and approves or requests additional information. Step 5: Once approved, we receive authorization and can begin treatment.
This process typically takes 5–10 business days. In urgent situations (acute suicidal ideation, severe functional impairment), we can request expedited review, often resulting in approval within 24–48 hours.
Cost Breakdown
If Spravato is approved by your insurance, your out-of-pocket cost depends on your specific plan. Most plans require either a copay or coinsurance. Typical costs include:
With insurance coverage: Copays typically range from $50–$150 per treatment session. Some high-deductible plans may require you to meet your deductible first, meaning you pay full price until the deductible is met. Without insurance: Spravato costs approximately $590 per nasal spray kit. Initial treatment requires 6–9 kits over 2 weeks, followed by weekly maintenance.
The total cost for initial induction can be $3,500–$5,000 without insurance. This is why insurance approval is so important for access.
What If Your Insurance Denies Spravato?
Insurance denials do happen, but they’re often appealable. Common reasons for initial denials include:
- Insufficient documentation of prior medication trials
- Insurance company believes additional trials should be attempted first
- Questions about whether criteria for treatment-resistant depression are truly met
If your claim is denied, we can appeal by providing additional documentation, clinical justification, or peer-to-peer review between our psychiatrist and the insurance company’s medical director. Many appeals are successful.
Patient Assistance Programs
Janssen Pharmaceuticals, the manufacturer of Spravato, offers patient assistance programs for patients whose insurance denies coverage or doesn’t cover the full cost. These programs can significantly reduce or eliminate out-of-pocket costs based on income. We can help you apply for these programs at Next Step Psychiatry.
Special Considerations in Georgia and Gwinnett County
Georgia expanded Medicaid in recent years, improving access to psychiatric treatments. If you’re uninsured or underinsured, Georgia Medicaid may cover Spravato. We can discuss your eligibility and help with applications. For patients in Lilburn and Gwinnett County with commercial insurance, most major carriers now cover Spravato.
Our Role in Getting You Approved
At Next Step Psychiatry, we take the insurance burden seriously. Our clinical team handles prior authorization paperwork. We gather your medical records, document prior treatment trials thoroughly, and submit compelling clinical justifications. We respond to insurance requests for additional information promptly. If denials occur, we appeal aggressively. Our goal is removing barriers so you can focus on getting the treatment you need.
Getting Started
If you believe Spravato might help your treatment-resistant depression, the first step is a consultation with our psychiatrist. We’ll evaluate your case, review your insurance coverage, discuss the approval process, and give you realistic expectations about cost and timeline. Don’t let insurance uncertainty prevent you from exploring this potentially life-changing treatment.
Call 678-437-1659 to discuss Spravato and insurance coverage options.
This article is for informational purposes only and is not a substitute for professional medical advice. If you or someone you know is in crisis, call 911 or the 988 Suicide & Crisis Lifeline.